Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer.

Abstract

The concentration of total sialic acid (TSA) is increased in the plasma of patients with many types of cancer. The purpose of this study was to assess the usefulness of the TSA marker in predicting the efficacy of the treatment, and to compare TSA with two common markers, carcinoembryonic antigen (CEA) and the carbohydrate antigen 19-9 (CA 19-9). The study… (More)

Topics

Cite this paper

@article{Painbeni1997PlasmaSA, title={Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer.}, author={T Painbeni and Erick Gamelin and A Cailleux and Antoine Le Bouil and Michelle Boisdron-Celle and Alain Daver and Francis Larra and P. Allain}, journal={European journal of cancer}, year={1997}, volume={33 13}, pages={2216-20} }